Sanne Lysbet de Haas

Promotion of sleep by targeting the orexin system in rats, dogs and humans

Catherine Brisbare‐Roch, Jasper Dingemanse, Ralf Koberstein et al. · Nature Medicine · 2007 · 564 citations

Animal Physiology, Sleep Disorders, Sleep +15

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

Leisha A. Emens, Francisco J. Esteva, Mark Beresford et al. · The Lancet Oncology · 2020 · 363 citations

Breast Oncology, Oncology, Pharmacology +7

Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer

José Baselga, Gail D. Lewis Phillips, Sunil Verma et al. · Clinical Cancer Research · 2016 · 221 citations · Full text

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

D.W. Miles, Sanne Lysbet de Haas, Luc Dirix et al. · British Journal of Cancer · 2013 · 154 citations · Full text

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA_Aα_2,3subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

Sanne Lysbet de Haas, Saco J. de Visser, J. P. Van Der Post et al. · Journal of Psychopharmacology · 2007 · 105 citations